Kevin A. Buczkowski
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Mycobacterium research and diagnosis, Histone Deacetylase Inhibitors Research, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, RNA modifications and cancer
Most-Cited Works
- → Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints(2016)1,544 cited
- → STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment(2016)618 cited
- → Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer(2016)158 cited
- → Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression(2017)140 cited
- → NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model(2018)51 cited
- → NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy(2015)30 cited
- → Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Harbors Frequent Splicesosome Mutations That Cause Aberrant RNA Splicing Affecting Genes Critical in pDC Differentiation and Function(2016)6 cited
- → Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patient-Derived Xenografts Are Faithful Genomic and Phenotypic Models of Primary Leukemia and Respond to the IL3 Receptor Targeting Agent SL-401 In Vivo(2015)2 cited
- → Supplementary method figure from STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment(2023)